Lemaitre Vascular INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
LeMaitre Vascular, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, executive compensation approval, and auditor ratification.
NASDAQ
DEFA14A: LeMaitre Vascular Urges Stockholders to Vote FOR Director Nominees Despite ISS Recommendation
LeMaitre Vascular is urging stockholders to vote in favor of its three director nominees, including the CEO, President, and an independent director, despite a recommendation from Institutional Shareholder Services (ISS) to withhold votes.
NASDAQ
LeMaitre Vascular, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
LeMaitre Vascular will hold its 2025 Annual Meeting of Stockholders on June 2, 2025, to vote on director elections, executive compensation, and auditor ratification.
NASDAQ
LeMaitre Vascular is soliciting proxies for its 2024 Annual Meeting of Stockholders, focusing on director elections, executive compensation, and approval of an amended stock option plan.